These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 21519359

  • 41. The first multicenter and randomized clinical trial of herbal Fufang for treatment of postmenopausal osteoporosis.
    Zhu HM, Qin L, Garnero P, Genant HK, Zhang G, Dai K, Yao X, Gu G, Hao Y, Li Z, Zhao Y, Li W, Yang J, Zhao X, Shi D, Fuerst T, Lu Y, Li H, Zhang X, Li C, Zhao J, Wu Q, Zhao SJ.
    Osteoporos Int; 2012 Apr; 23(4):1317-27. PubMed ID: 21505910
    [Abstract] [Full Text] [Related]

  • 42. Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial.
    Cheung AM, Tile L, Cardew S, Pruthi S, Robbins J, Tomlinson G, Kapral MK, Khosla S, Majumdar S, Erlandson M, Scher J, Hu H, Demaras A, Lickley L, Bordeleau L, Elser C, Ingle J, Richardson H, Goss PE.
    Lancet Oncol; 2012 Mar; 13(3):275-84. PubMed ID: 22318095
    [Abstract] [Full Text] [Related]

  • 43. Intranasal salmon calcitonin for the prevention and treatment of postmenopausal osteoporosis.
    Ellerington MC, Hillard TC, Whitcroft SI, Marsh MS, Lees B, Banks LM, Whitehead MI, Stevenson JC.
    Calcif Tissue Int; 1996 Jul; 59(1):6-11. PubMed ID: 8661976
    [Abstract] [Full Text] [Related]

  • 44. Randomized Controlled Trial Evaluating the Use of Zoledronic Acid in Duchenne Muscular Dystrophy.
    Zacharin M, Lim A, Gryllakis J, Siafarikas A, Jefferies C, Briody J, Heather N, Pitkin J, Emmanuel J, Lee KJ, Wang X, Simm PJ, Munns CF.
    J Clin Endocrinol Metab; 2021 Jul 13; 106(8):2328-2342. PubMed ID: 33954789
    [Abstract] [Full Text] [Related]

  • 45. Growth hormone favorably affects bone turnover and bone mineral density in patients with short bowel syndrome undergoing intestinal rehabilitation.
    Tangpricha V, Luo M, Fernández-Estívariz C, Gu LH, Bazargan N, Klapproth JM, Sitaraman SV, Galloway JR, Leader LM, Ziegler TR.
    JPEN J Parenter Enteral Nutr; 2006 Jul 13; 30(6):480-6. PubMed ID: 17047171
    [Abstract] [Full Text] [Related]

  • 46. [Effects of salmon calcitonin in treatment of osteoporosis in patients undergoing dialysis].
    Wang SX, Li H.
    Zhonghua Yi Xue Za Zhi; 2008 Feb 05; 88(6):387-90. PubMed ID: 18581891
    [Abstract] [Full Text] [Related]

  • 47. Adequate calcium intake during long periods improves bone mineral density in healthy children. Data from the Childhood Obesity Project.
    Closa-Monasterolo R, Zaragoza-Jordana M, Ferré N, Luque V, Grote V, Koletzko B, Verduci E, Vecchi F, Escribano J, Childhood Obesity Project Group.
    Clin Nutr; 2018 Jun 05; 37(3):890-896. PubMed ID: 28351509
    [Abstract] [Full Text] [Related]

  • 48. Risedronate for prevention of bone mineral density loss in patients receiving high-dose glucocorticoids: a randomized double-blind placebo-controlled trial.
    Mok CC, Tong KH, To CH, Siu YP, Ma KM.
    Osteoporos Int; 2008 Mar 05; 19(3):357-64. PubMed ID: 18038273
    [Abstract] [Full Text] [Related]

  • 49. Musculoskeletal system in children and adolescents with inflammatory bowel disease: normal muscle force, decreased trabecular bone mineral density and low prevalence of vertebral fractures.
    Maratova K, Hradsky O, Matyskova J, Copova I, Soucek O, Sumnik Z, Bronsky J.
    Eur J Pediatr; 2017 Oct 05; 176(10):1355-1363. PubMed ID: 28840427
    [Abstract] [Full Text] [Related]

  • 50. Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trial.
    Cooper C, Harvey NC, Bishop NJ, Kennedy S, Papageorghiou AT, Schoenmakers I, Fraser R, Gandhi SV, Carr A, D'Angelo S, Crozier SR, Moon RJ, Arden NK, Dennison EM, Godfrey KM, Inskip HM, Prentice A, Mughal MZ, Eastell R, Reid DM, Javaid MK, MAVIDOS Study Group.
    Lancet Diabetes Endocrinol; 2016 May 05; 4(5):393-402. PubMed ID: 26944421
    [Abstract] [Full Text] [Related]

  • 51. Low bone mineral density in children and adolescents with inflammatory bowel disease: a population-based study from Western Sweden.
    Schmidt S, Mellström D, Norjavaara E, Sundh SV, Saalman R.
    Inflamm Bowel Dis; 2009 Dec 05; 15(12):1844-50. PubMed ID: 19408319
    [Abstract] [Full Text] [Related]

  • 52. A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: a pilot study.
    Bernstein CN, Seeger LL, Anton PA, Artinian L, Geffrey S, Goodman W, Belin TR, Shanahan F.
    Aliment Pharmacol Ther; 1996 Oct 05; 10(5):777-86. PubMed ID: 8899087
    [Abstract] [Full Text] [Related]

  • 53. Effects of oral alendronate on BMD in adult patients with osteogenesis imperfecta: a 3-year randomized placebo-controlled trial.
    Chevrel G, Schott AM, Fontanges E, Charrin JE, Lina-Granade G, Duboeuf F, Garnero P, Arlot M, Raynal C, Meunier PJ.
    J Bone Miner Res; 2006 Feb 05; 21(2):300-6. PubMed ID: 16418786
    [Abstract] [Full Text] [Related]

  • 54. Randomized trial of once-weekly parathyroid hormone (1-84) on bone mineral density and remodeling.
    Black DM, Bouxsein ML, Palermo L, McGowan JA, Newitt DC, Rosen E, Majumdar S, Rosen CJ, PTH Once-Weekly Research (POWR) Group.
    J Clin Endocrinol Metab; 2008 Jun 05; 93(6):2166-72. PubMed ID: 18349061
    [Abstract] [Full Text] [Related]

  • 55. Risk factors for low bone mineral density in pediatric inflammatory bowel disease: the positive role of physical activity.
    Nobile S, Grand RJ, Pappa HM.
    Eur J Gastroenterol Hepatol; 2018 Apr 05; 30(4):471-476. PubMed ID: 29438136
    [Abstract] [Full Text] [Related]

  • 56. Effects of calcium, dairy product, and vitamin D supplementation on bone mass accrual and body composition in 10-12-y-old girls: a 2-y randomized trial.
    Cheng S, Lyytikäinen A, Kröger H, Lamberg-Allardt C, Alén M, Koistinen A, Wang QJ, Suuriniemi M, Suominen H, Mahonen A, Nicholson PH, Ivaska KK, Korpela R, Ohlsson C, Väänänen KH, Tylavsky F.
    Am J Clin Nutr; 2005 Nov 05; 82(5):1115-26; quiz 1147-8. PubMed ID: 16280447
    [Abstract] [Full Text] [Related]

  • 57. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
    Lazzari AA, Dussault PM, Thakore-James M, Gagnon D, Baker E, Davis SA, Houranieh AM.
    Epilepsia; 2013 Nov 05; 54(11):1997-2004. PubMed ID: 24010637
    [Abstract] [Full Text] [Related]

  • 58. The effect of high-dose vitamin D3 supplementation on bone mineral density in subjects with prediabetes.
    Larsen AU, Grimnes G, Jorde R.
    Osteoporos Int; 2018 Jan 05; 29(1):171-180. PubMed ID: 28921338
    [Abstract] [Full Text] [Related]

  • 59. Longitudinal follow-up of bone mineral density in children with nephrotic syndrome and the role of calcium and vitamin D supplements.
    Gulati S, Sharma RK, Gulati K, Singh U, Srivastava A.
    Nephrol Dial Transplant; 2005 Aug 05; 20(8):1598-603. PubMed ID: 15956073
    [Abstract] [Full Text] [Related]

  • 60. A randomized, double-blind, multicenter, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of osteoporosis in postmenopausal women taking calcium and vitamin D.
    Henriksen K, Byrjalsen I, Andersen JR, Bihlet AR, Russo LA, Alexandersen P, Valter I, Qvist P, Lau E, Riis BJ, Christiansen C, Karsdal MA, SMC021 investigators.
    Bone; 2016 Oct 05; 91():122-9. PubMed ID: 27462009
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.